{"SPADE_UN_27070": {"Sequence Information": {"Peptide Name": "LTX-109, Voxvoganan, Lytixar", "Sequence": "RXR", "Sequence Length": 3, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Synthetic antimicrobial peptidomimetics with therapeutic potential.", "Pubmed ID": "18570363", "Reference": "J Med Chem. 2008;51:4306-4314", "Author": "Haug BE, Stensen W, Kalaaji M, Rekdal Ø, Svendsen JS", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/18570363"}, {"Title": "In vitro activities of LTX-109, a synthetic antimicrobial peptide, against methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, daptomycin-nonsusceptible, and linezolid-nonsusceptible Staphylococcus aureus.", "Pubmed ID": "22585222", "Reference": "Antimicrob Agents Chemother. 2012;56:4478-4482", "Author": "Saravolatz LD, Pawlak J, Johnson L, Bonilla H, Saravolatz LD 2nd, Fakih MG, Fugelli A, Olsen WM", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/22585222"}, {"Title": "Antimicrobial Peptides Incorporating Halogenated Marine-Derived Amino Acid Substituents.", "Pubmed ID": "37312845", "Reference": "ACS Med Chem Lett. 2023;14:802-809", "Author": "Craig AJ, Ermolovich Y, Cameron AJ, Rodler A, Wang H, Hawkes JA, Hubert M, Björkling F, Molchanova N, Brimble MA, Moodie LWK, Svenson J", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/37312845"}, {"Title": "A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption", "Pubmed ID": "21732630", "Reference": "J Med Chem. 2011;54:5786-5795", "Author": "Isaksson J, Brandsdal BO, Engqvist M, Flaten GE, Svendsen JS, Stensen W", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/21732630"}], "SPADE ID": "SPADE_UN_27070", "Similar Sequences": [{"SPADE_ID": "SPADE_N_00066", "Similarity": 1.0, "Sequence": "ATYYGNGLYCNKEKCWVDWNQAKGEIGKIIVNGWVNHGPWAPRR"}, {"SPADE_ID": "SPADE_N_00076", "Similarity": 1.0, "Sequence": "VNYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP"}, {"SPADE_ID": "SPADE_N_00079", "Similarity": 1.0, "Sequence": "FVYGNGVTSILVQAQFLVNGQRRFFYTPDK"}], "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=90 µg/ml,Human erythrocytes:4.23% Hemolysis=100 µM,Human erythrocytes:50% Hemolysis=175 µg/ml", "Target Organism": "Escherichia coli ATCC 25922(MIC=7.5µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=5µg/ml),Staphylococcus aureus ATCC 25923(MIC=2.5µg/ml),Staphylococcus aureus ATCC 33591(MIC=2.5µg/ml),Staphylococcus epidermidis ATCC 27626(MIC=1.0µg/ml),Staphylococcus aureus CCUG 43316(MIC=2.5µg/ml),Staphylococcus aureus(MIC=2-4µg/ml),Staphylococcus aureus(MBC=2-8µg/ml),Escherichia coli ATCC 25922(MIC=2-4µM),Staphylococcus aureus ATCC 29213(MIC=2-4µM),Candida albicans SC5314(MIC=4µM),Candida utilis(MIC=2µM),Aspergillus fumigatus(MIC=8µM),Human cervical carcinoma HeLa(IC50=46.6µM),Escherichia coli ATCC 25922(MIC=3µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=8µg/ml),Staphylococcus aureus ATCC 25923(MIC=2µg/ml)"}}}